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Purpose: Recent work has suggested that insulin-like growth factor 1 (IGF-1) gene polymorphisms are genetically linked
with high-grade myopia (HM), which is a complex-trait eye disorder in which numerous candidate loci and genes are
thought to play a role. We investigated whether the IGF-1 single nucleotide polymorphisms (SNPs) rs6214, rs10860860,
and rs2946834 are associated with HM (≤-6.0 diopters [D]) and any myopia (≤-0.5 D) phenotype in Polish families.
Methods: Forty-two multiplex HM Polish families, of whom 127 had HM, participated in the study. All of the family
members (n=306) underwent a detailed ophthalmic examination, including axial length measurements. The IGF-1 SNPs
rs6214, rs10860860, and rs2946834 were evaluated by PCR-RFLP and direct sequencing methods. Both Family-Based
Association Test (FBAT) and family-based Pedigree Disequilibrium Test (PDT) were used to examine the potential
association of the IGF-1 SNPs rs6214, rs10860860, and rs2946834 with HM or any myopia. To determine the distribution
of the HM-associated SNPs rs6214 and rs10860860, 543 unrelated individuals from the general Polish population were
also analyzed.
Results: We found no significant association between the IGF-1 SNPs rs6214, rs10860860, and rs2946834 and HM or
any myopia phenotype in Polish HM families. In the general Polish population, the minor allele frequencies of the SNPs
rs6214 and rs10860860 did not deviate significantly from the distribution reported for European populations (p=0.629).
In the FBAT analysis under the dominant model, the haplotype consisted of T allele of rs10860860, with C allele of
rs2946834 of IGF-1 was found less frequently transmitted to HM individuals (p=0.0065), pointing to a nonassociated or
protective haplotype.
Conclusions: Our results do not support recent studies reporting an association of the SNPs rs6214, rs10860860, and
rs2946834 in the IGF-1 gene with HM and any myopia phenotypes. Further replication studies involving other populations
are needed to investigate the possible role of IGF-1 as a potential myopia candidate gene.
Myopia affects 25% of the Western world, making this
condition the most common eye disorder in the West and
constituting a significant public health and economic problem
[1,2]. The cost of optical correction to provide clear distinct
vision is considerable. Moreover, the development of high-
grade myopia (HM; ≤-6.0 diopters [D]) [3] is a significant risk
factor  for  other  ocular  diseases,  including  chorioretinal
degeneration,  glaucoma,  retinal  detachment,  premature
cataracts,  and  finally  blindness  [4-6].  Consequently,  great
efforts have been undertaken to identify and understand the
mechanisms underlying the development and progression of
myopia.
Myopia has a diverse etiology, with both environmental
and genetic factors believed to be involved in the condition’s
development  and  progression.  The  environmental  factors
implicated in myopia include near work, light exposure, lack
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of physical activity, diet, a higher level of education, and
urbanization [7-10]. However, HM is highly heritable and
often  appears  as  familial  ocular  disorder,  where  genetic
predisposition  seems  to  be  a  dominant  factor  of  its
development  and  progression  [11-13].  Each  type  of
Mendelian inheritance for familial HM has been described
[14,15].  To  date,  several  genetic  loci  for  nonsyndromic
myopia (MYP) have been mapped, including 12 loci linked to
HM: MYP1, chromosome Xq28 (OMIM 310460) [16,17];
MYP2 18p11.31 (OMIM 160700) [18,19]; MYP3 12q21-q23
(OMIM 603221) [20-22]; MYP4 7q36 (OMIM 608367) [23];
MYP5 17q21-q22 (OMIM 608474) [24]; MYP11 4q22-q27
(OMIM 609994) [25]; MYP12 2q37.1 (OMIM 609995) [26];
MYP13 Xq23-q25 (OMIM 300613) [27]; MYP15 10q21.1
(OMIM  612717)  [28];  MYP16  5p15.33-p15.2  (OMIM
612554) [29]; MYP18 14q22.1-q24.2 (OMIM 255500) [30],
and MYP19 5p15.1-p13.3 (OMIM 613969) [31]. Moreover,
two  recent  independent  genome-wide  association  studies
involving large cohorts of refractive error patients identified
loci at chromosome 15q14 and 15q25 [32,33].
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2428Candidate gene association studies have revealed several
HM susceptibility genes, including: collagen, type I, alpha 1
(COL1A1)  [34,35],  transforming  growth  factor,  beta  1
(TGFB1) [36,37], transforming growth beta-induced factor
(TGIF) [38,39], lumican (LUM) [40,41], hepatocyte growth
factor (HGF) [42,43], myocilin (MYOC) [44,45], paired box
6 (PAX6) [46,47], and uromodulin-like 1 (UMODL1) [48].
However,  positive  results  have  not  been  replicated,  and
inconsistent data have been published. Thus, the causative
mutation(s)  has  not  yet  been  found,  suggesting  genetic
heterogeneity among studied populations.
Recently,  Metlapally  et  al.  [49]  reported  a  genetic
association between the three single nucleotide polymorphism
(SNP)s  rs6214,rs10860860,  and  rs2946834  and  familial
myopia in a large, international cohort of myopia pedigrees of
Caucasian origin, suggesting that insulin-like growth factor 1
(IGF-1) may be a candidate gene for HM. These three SNPs
are located within the MYP3 locus (OMIM 603221) mapped
to chromosomal region 12q21-q23. This locus was previously
reported to be associated with autosomal dominant HM [20,
21].  The  SNP  rs6214  (reference  allele  G)  lies  in  the  3′-
untranslated  region  (UTR)  of  IGF-1  (OMIM  147440),
whereas  the  SNPs  rs10860860  (reference  allele  A)  and
rs2946834 (reference allele C) are located in the noncoding
sequence in close proximity to IGF-1.
The  IGF-1  gene  encodes  insulin-like  growth  factor
(pIGF-1), which is a member of the signaling system involved
in  development,  cellular  growth,  differentiation,  protein
translation, metabolism, apoptosis, and aging [50,51]. The
association of IGF-1 with numerous human diseases, such as
diabetes [52], cancer [53], and growth failure [54] has been
reported. IGF-1 has been also implicated in ocular diseases,
including  retinopathy  of  prematurity  [55,56],  age-related
macular degeneration [57], and diabetic retinopathy [58,59].
However, for IGF-1 to be considered as a candidate gene for
HM, previously published findings need to be replicated.
In the present study, we tested the association of rs6214,
rs10860860, and rs2946834 in the IGF-1 gene with HM and
any myopia phenotype in 42 Polish families. Our findings do
not confirm the results reported previously for another myopic
Caucasian  cohort,  however  which  was  different  from  the
Polish population [49]. To our knowledge, this is the first
replication study to screen genetic variants in IGF-1, which
previous work has suggested may be associated with any
myopia and HM phenotypes.
METHODS
Subjects: Forty-two multigenerational Polish HM families
were enrolled in the study. The subjects were classified into
three  groups,  including:  1)  affected  individuals  (HM),  2)
individuals  with  an  unknown  status,  and  3)  unaffected
persons. All of the affected individuals had: A) bilateral axial
HM in excess of or equal to −6.0 D (≤-6.0 D) in at least one
eye and in excess of or equal to −5.0 D (≤-5.0 D) in the second
eye, B) a history of onset of myopia at age ≤15 years, and C)
a  multiplex  family  with  affected  relatives  in  different
generations.  Individuals  who  were  classified  as  unknown
were: A) all children ≤15 years unless they fulfilled criteria
for affected status as specified above, or B) individuals who
have myopia with −6.0 D< X ≤-4.0 D, or C) individuals with
a refractive error of ≤-6.0 D for one eye and a refractive error
>-5.0 D for the second eye, or D) individuals with late age of
onset  (>15  years).  All  of  the  remaining  individuals  were
considered unaffected, including hyperopic, normal seeing,
and myopic subjects with a spherical refractive error (SPH) in
the range from ≤-0.5 D to >-4.0 D.
The  SNPs  rs6214,  rs10860860,  and  rs2946834  were
examined  in  306  subjects,  including  127  with  HM,  148
unaffected, and 31 individuals with an unknown status. In
addition,  to  determine  the  distribution  of  the  genotypes
possibly associated with HM (rs6214 and rs10860860) [49]
in  the  general  Polish  population,  543  unrelated  white
Caucasian  individuals  were  examined.  The  population
samples were collected randomly and anonymously, and the
myopia status was not determined [60].
All  of  the  individuals  (affected,  unaffected,  and
unknown)  who  participated  in  this  study  underwent  a
complete ophthalmic assessment, including a visual acuity
testing,  best-corrected  visual  acuity  testing,  a  slit  lamp
evaluation,  intraocular  pressure  examination,  fundoscopy,
axial length determination, keratometry, and refractometry.
The detailed clinical evaluation and pedigrees of Polish HM
families have been previously described [61]. The clinical
characteristics of all of the individuals examined are shown in
brief in Table 1. The SPH was used to assign HM status.
In addition, any myopia phenotype status was established
in  reference  to  the  criteria  published  by  Metlapally  et  al.
[49], who defined any myopia phenotype as ≤-0.5 D based on
SPH. The clinical information data for this category are shown
in Appendix 1.
The research protocol was approved by the Institutional
Review Board at Poznan University of Medical Sciences in
Poland.  In  accordance  with  the  Declaration  of  Helsinki,
written informed consent was obtained for the genetic studies
from all of the participating family members and individuals
from the general Polish population group.
Genotyping  of  IGF-1  SNPs  rs6214,  rs10860860,  and
rs2946834: The SNPs rs6214 and rs10860860 were analyzed
by PCR-RFLP and direct sequencing methods. Two pairs of
primers were used to amplify DNA harboring the analyzed
SNPs.  The  amplicons  were  digested  by  the  restriction
enzymes  TaiI  and  NdeI,  respectively,  according  to  the
manufacturer’s instructions (Fermentas, Vilnius, Lithuania).
The  detailed  PCR-RFLP  protocols  used  in  this  study  are
provided in Appendix 2. In addition, all homozygous rs6214
AA  and  rs10860860  TT  samples  were  verified  by  direct
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2430sequencing  using  the  BigDye®  Terminator  v3.1  Cycle
Sequencing Kit (Applied Biosystems [ABI], Foster City, CA)
and an ABI 3730xl analyzer. The results were analyzed by
Sequencher®  Software  4.10.1  (Gene  Codes  Corporation,
Ann. Arbor, MI). Due to a lack of a restriction site for SNP
rs2946834,  we  analyzed  this  polymorphism  by  direct
sequencing as described above. The detailed PCR protocol, as
well as the primer sequences, are given in Appendix 2.
All of the primer pairs used in this study were designed
with the Primer3 v.0.4.0 tool and synthesized by Genomed
Co. (Warsaw, Poland).
Statistical analyses: PEDCHECK version 1.1 [62] was used
to determine Mendelian inconsistencies within families. Plink
software [63] was used to examine the genotype distribution
of the SNPs tested for departures from expectations of the
Hardy–Weinberg equilibrium (HWE).
Haploview  [64]  was  used  to  estimate  the  linkage
disequilibrium (LD) pattern of the analyzed SNPs in the Polish
HM families and compare with data pertaining to the CEU
population (HapMap Public Release #27).
We  tested  for  an  association  between  the  rs6214,
rs10860860,  and  rs2946834  polymorphisms  of  the  IGF-1
gene  and  HM  and  any  myopia  using  the  Family-Based
Association  Test  (FBAT,  version  1.7.2).  FBAT  is  a
generalized  approach  derived  from  the  transmission/
disequilibrium test (TDT) [65], which allows the genotype
distribution  observed  in  the  affected  offspring  and  the
expected  distribution  to  be  evaluated.  The  models  of
inheritance  examined  by  FBAT  included  the  additive,
dominant, and recessive models [66,67]. The FBAT analysis
was performed based on the compound null hypothesis of no
linkage and no association between the phenotype and the
genetic variant. To analyze the haplotype using FBAT, 42
multiplex  Polish  families  were  divided  into  122  nuclear
families (two parents and their offspring), and they were tested
using  a  two-stage  procedure.  First,  the  SNPs  rs6214,
rs10860860,  and  rs2946834  were  examined  separately.
Testing was then undertaken for possible haplotypes of the
specific  alleles  of  rs6214,  rs10860860,  and  rs2946834.
Analyses  in  which  there  were  less  than  ten  informative
families  for  a  particular  marker  were  excluded  from
consideration. Unaffected individuals were included in the
study to increase the statistical power of the FBAT analysis.
In  addition,  to  verify  the  FBAT  results,  the  genetic
association between the three selected polymorphisms of the
IGF-1 gene and HM and any myopia phenotypes were tested
using the family-based Pedigree Disequilibrium Test (PDT,
version 5.1) [68] as described by Metlapally et al. [49]. The
PDT analysis program evaluates evidence of LD in general
pedigree data.
RESULTS
The genotype distribution and allele frequencies in affected,
unaffected, and individuals with unknown status, as well as in
the general Polish population group, are shown in Table 2. All
genotypes of examined SNPs were tested for HWE, and no
significant deviations were found.
The minor allele frequencies estimated for the general
Polish population group were 0.372 and 0.312 for rs6214 A
and rs10860860 T, respectively. The coexistence of two minor
homozygous genotypes of rs6214 AA and rs10860860 TT
was  observed  in  3.1%  of  individuals  (Table  2).  In  HM
families, the minor allele frequencies for the SNPs analyzed
were 0.366, 0.339, and 0.320 for rs6214 A, rs10860860 T, and
rs2946834 T, respectively, for HM and 0.367, 0.324, and
0.275, respectively, for any myopia phenotype (Table 2). In
the HM category, the coexistence of two minor homozygous
genotypes of the SNPs rs6214 AA and rs10860860 TT was
observed  in  5.5%  and  5.4%  of  affected  and  unaffected
subjects,  respectively.  The  coexistence  of  two  minor
homozygous genotypes of rs6214 AA and rs2946834 TT was
1.6% and 0%, whereas, the coexistence of rs10860860 TT and
rs2946834 TT, was observed in 6.4% of affected and 2.0% of
unaffected subjects, respectively (Table 2). The coexistence
of  three  minor  genotypes  of  the  SNPs  rs6214  AA,
rs10860860 TT, and rs2946834 TT analyzed was found in
0.8% of affected individuals and was absent in unaffected
subjects (Table 2).
The FBAT and PDT analyses revealed no significant
association between the rs6214, rs10860860, and rs2946834
SNPs analyzed and HM, as well as no significant association
with  any  myopia  phenotype.  The  haplotype  consisted  of
alleles  T  of  rs10860860,  and  alleles  C  of  rs2946834  of
IGF-1  was  found  less  frequently  in  HM  individuals  than
expected (p=0.0065). Table 3 presents the Z scores and p
values  for  the  tested  IGF-1  polymorphisms  and  the
haplotypes. Moreover, we found a random distribution of
genotypes and alleles of the SNPs examined in the Polish HM
families (Figure 1 and Appendix 3).
The  analysis  of  LD  between  rs6214,  rs2946834,  and
rs10860860 did not reveal high LD between SNP pairs in the
Polish  HM  families.  Moreover,  the  r2  values  for  pairs  of
markers were similar in Polish HM families and the CEU
population (p=0.629).
DISCUSSION
Genetic  association  studies,  including  case-control  and
family-base  studies,  have  been  widely  used  to  search  for
genetic factors involved in human diseases, including HM
[69,70].  Recently,  Metlapally  et  al.  [49]  suggested  that
IGF-1 may be a candidate gene for familial myopia based on
a  positive  association  between  the  SNPs  rs6214  and
rs10860860 and the HM phenotype and the SNPs rs6214,
rs10860860, and rs2946834 and any myopia phenotype.
The  SNP  rs6214  is  considered  to  be  a  functional
polymorphism  due  to  its  location  in  the  3′-UTR  of  the
IGF-1 gene. The 3′-UTR, a noncoding sequence, contains
Molecular Vision 2011; 17:2428-2439 <http://www.molvis.org/molvis/v17/a264> © 2011 Molecular Vision
2431TABLE 2. GENOTYPE DISTRIBUTION AND ALLELE FREQUENCY OF IGF-1 GENE SNPS RS6214, RS10860860, AND RS2946834.
rs6214 GG 51 40.1 54 36.5 13 41.9 82 39.6 27 34.6 9 42.9 209 38.5
  GA 59 46.5 78 52.7 13 41.9 98 47.3 43 55.1 9 42.9 264 48.6
  AA 17 13.4 16 10.2516.2 27 13.1 8 10.3 3 14.2 70 12.9
  G 16
1
63.4 186 62.8 39 62.9 262 63.3 97 62.2 27 64.3 682 62.8
  A 93 36.6 110 37.2 23 37.1 152 36.7 59 37.8 15 35.7 404 37.2
rs10860860 AA 57 44.9 60 40.5 15 48.4 96 46.4 23 29.5 13 61.9 248 45.7
  AT 54 42.5 75 50.7 14 45.2 88 42.5 48 61.5 7 33.3 251 46.2
  TT 16 12.6 13 8.826.4 23 11.1 7 9.0 1 4.8 44 8.1
  A 16
8
66.1 195 65.9 44 71.0 280 67.6 94 60.3 33 78.6 747 68.8
  T 86 33.9 101 34.1 18 29.0 134 32.4 62 39.7 9 21.4 339 31.2
rs2946834 CC 61 48.8 72 49.0 14 45.2 109 53.4 29 37.2 9 42.9 - -
  CT 48 38.4 61 41.5 14 45.2 78 38.2 37 47.4 8 38.1 - -
  TT 16 12.8 14 9.539.7 17 8.3 12 15.4 4 19.0 - -
  C 17
0
68 205 69.7 42 67.7 296 72.5 95 60.9 26 61.9 - -
  T 80 32 89 30.3 20 32.3 112 27.5 61 39.1 16 38.1 - -
rs6214/
rs10860860
GG / AA 35 27.6 40 27.0929.0 61 29.5 15 19.2 8 38.1 154 28.4
  GG / AT 13 10.2 13 8.8 4 12.9 18 8.7 11 14.1 1 4.8 53 9.8
  GG / TT 3 2.4 1 0.700.0 3 1.4 1 1.3 002 0.4
  GA / AA 19 14.9 19 12.8516.1 31 15.0 7 9.0 5 23.8 81 14.9
  GA / AT 34 26.8 55 37.2825.8 60 29.0 33 42.3 4 19.0 158 29.0
  GA / TT 6 4.7 4 2.700.0 7 3.4 3 3.8 0 0 25 4.6
  AA / AA 3 2.4 1 0.713.2 4 1.9 1 1.3 0 0 13 2.4
  AA / AT 7 5.5 7 4.726.5 10 4.8 4 5.2 2 9.5 40 7.4
  AA / TT 7 5.5 8 5.426.5 13 6.3 3 3.8 1 4.8 17 3.1
rs2946834/
rs6214
CT / GG 18 14.4 18 12.2619.4 28 13.7 12 15.4 2 9.5 - -
  CT / GA 24 19.2 32 21.8722.6 41 20.1 18 23.1 4 19.0 - -
  CC / AA 9 7.2 5 3.4 4 12.9 16 7.8 1 1.3 1 4.8 - -
  TT / AA 2 1.6 0 0.000.0 2 1.0 0 0.0 0 0.0 - -
  CT / AA 6 4.8 11 7.513.2 9 4.4 7 9.0 2 9.5 - -
  CC / GA 27 21.6 37 25.2516.1 48 23.5 18 23.1 3 14.3 - -
  CC / GG 25 20 30 20.4516.1 45 22.1 10 12.8 5 23.8 - -
  TT / GA 7 5.6 9 6.113.2 8 3.9 7 9.0 2 9.5 - -
  TT / GG 7 5.6 5 3.426.5 7 3.4 5 6.4 2 9.5 - -
rs10860860/
rs2946834
AT / CT 29 23.2 42 28.6516.1 43 21.1 29 37.2 4 19.0 - -
  TT / TT 8 6.4 3 2.000.0 8 3.9 3 3.8 0 0.0 - -
  TT / CT 5 4 7 4.813.2 9 4.4 4 5.1 0 0.0 - -
  AT / TT 7 5.6 6 4.139.7 8 3.9 6 7.7 2 9.5 - -
  AA / CC 42 33.6 42 28.6722.6 68 33.3 16 20.5 7 33.3 - -
  AA / TT 1 0.8 5 3.400.0 1 0.5 3 3.8 2 9.5 - -
  AA / CT 14 11.2 12 8.2 8 25.8 26 12.7 4 5.1 4 19.0 - -
  AT / CC 16 12.8 27 18.4619.4 35 17.2 13 16.7 1 4.8 - -
  TT / CC 3 2.4 3 2.013.2 6 2.9 0 0.0 1 4.8 - -
rs10860860/
rs2946834/
rs6214
AA / CC / AA 3 2.4 1 0.713.2 4 2.0 1 1.3 0 0.0 - -
  AA / CC / GA 15 12.0 13 8.813.2 21 10.3 6 7.7 2 9.5 - -
  AA / CC / GG 24 19.2 28 19.0516.1 43 21.1 9 11.5 5 23.8 - -
  AA / CT / GA 4 3.2 4 2.7 4 12.9 10 4.9 0 0.0 2 9.5 - -
  AA / CT / GG 10 8.0 8 5.4 4 12.9 16 7.8 4 5.1 2 9.5 - -
  AA / TT / GA 0 0.0 2 1.400.0 0 0.0 1 1.3 1 4.8 - -
  AA / TT / GG 1 0.8 3 2.000.0 1 0.5 2 2.6 1 4.8 - -
  AT / CC / AA 3 2.4 1 0.726.5 6 2.9 0 0.0 0 0.0 - -
  AT / CC / GA 12 9.6 24 16.3412.9 27 13.2 12 15.4 1 4.8 - -
  AT / CC / GG 1 0.8 2 1.400.0 2 1.0 1 1.3 0 0.0 - -
  AT / CT / AA 3 2.4 6 4.100.0 3 1.5 4 5.1 2 9.5 - -
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High-grade myopia Any myopia      
Affected Unaffected Unknown Affected Unaffected Unknown
Population
     group
SNP SNP genotype/
allele
n % n % n % n % n % n % n %regulatory  motifs  crucial  for  gene  expression,  mRNA
stability, and cellular location of mRNA or the binding of
microRNA  [71,72].  Previous  work  has  suggested  that
sequence changes in this region may alter mRNA stability and
lead to altered binding activity to microRNAs, which might
downregulate  gene  expression  by  mRNA  cleavage  or
translational repression [73,74].
The  chick  model  of  experimental  myopia  suggests  a
possible role for IGF-1 in eye growth and elongation; and
therefore, in myopia development and progression. Insulin
and IGF-1 injected into chick eyes resulted in an increase in
the rate of axial length, ocular elongation, and the anterior
chamber  depth  [75,76].  However,  these  findings  do  not
entirely  correspond  with  published  data  for  the  mammal
model, with IGF-1 reported to be a weak factor for mouse lens
epithelial cell differentiation and proliferation [77,78].
Cordian et al. [9] stated that myopia may be related to
impaired  metabolic  control.  They  observed  that  enhanced
scleral growth may result from increased levels of insulin and
insulin-like  growth  hormones.  Compared  with  untreated
patients with Laron syndrome (LS), susceptibility to mild
myopia  has  been  observed  in  patients  with  LS  (OMIM
262500) who received treatment with IGF-1. However, there
was no difference in axial length between IGF-1 treated LS
patients and healthy controls [79].
In  the  present  study,  we  investigated  the  previously
reported association of the SNPs rs6214, rs10860860, and
rs2946834 in the IGF-1 gene with familial HM or any myopia
phenotypes. The SNPs selected for the analysis were not in
LD in the Polish families; the r2 values for pairs of markers
were similar in the CEU population and in the Polish HM
families. Simultaneously, we estimated the allele distributions
of the selected SNPs (rs6214 and rs10860860) in the general
Polish population group. We found no significant differences
in minor allele frequencies observed in the general Polish
population (rs6214 A and rs10860860 T, 0.372 and 0.312,
respectively)  and  the  data  provided  by  HapMap  Public
Release  #28  for  CEU:  Utah  residents  with  Northern  and
Western  European  ancestry  from  the  Centre  d”Etude  du
Polymorphisme Humain (CEPH) collection (rs6214 A and
rs10860860 T, 0.425 and 0.350, respectively). In our family-
based study, we found no evidence of an association between
the SNPs rs6214, rs10860860, and rs2946834 in the IGF-1
gene  and  any  myopia  and  HM.  In  contrast  to  previously
published data [49], random distribution of genotypes and
alleles  were  observed  in  the  Polish  HM  families  that  we
examined. However, the haplotype consisted of allele T of
rs10860860, and allele C of rs2946834 of IGF-1 was found
less frequently in HM individuals than expected (p=0.0065),
pointing to a protective effect of the haplotype. These and
other allele haplotypes were not examined in the Metlapally
et al. [49] study.
Over the years, various studies have reported associations
between numerous nucleotide variants in several genes and
HM [30,42,44,80]. However, subsequent studies have failed
to  confirm  and  replicate  these  associations  [40,45,81,82].
Possible  reasons  for  the  observed  discrepancies  in  the
published HM data, especially in relation to complex genetic
traits,  include  (i)  ethnic  differences,  (ii)  sample  size,  (iii)
subject misclassification, (iv) power of association analyses,
and (v) criteria for statistical significance [83-85].
We  analyzed  a  homogenous  ethnic  group.  All  of  the
participants were Polish, white Caucasian, and of European
origin. Metlapally et al. [49] examined IGF-1 polymorphisms
in a large cohort of Caucasian HM families, but the subjects
were derived from different countries, and the majority of
families in their study were from the US (60%). European-
Americans  are  often  treated  as  a  homogeneous  group;
however, due to historical immigration, this cohort is formed
of diverse source populations [86].
Unlike the study by Metlapally et al. [49], we employed
distinct criteria to determine subjects’ HM status. Metlapally
et al. [49] based the HM state on SPH, as well as on spherical
equivalent (SE) error of −5.00 D or more in at least one eye.
We used more stringent criteria in our study. Subjects were
classified as affected based on SPH only and a −6.00 D or
more in at least one eye and −5.00 D in the second eye in
accordance with HM criteria described elsewhere [3]. In some
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TABLE 2. CONTINUED.
  AT / CT / GA 18 14.4 26 17.7 3 9.7 28 13.7 17 21.8 2 9.5 - -
  AT / CT / GG 8 6.4 10 6.8 2 6.5 12 5.9 8 10.3 0 0.0 - -
  AT / TT / AA 1 0.8 0 0.0 0 0.0 1 0.5 0 0.0 0 0.0 - -
  AT / TT / GA 3 2.4 5 3.4 1 3.2 4 2.0 4 5.1 1 4.8 - -
  AT / TT / GG 3 2.4 1 0.7 2 6.5 3 1.5 2 2.6 1 4.8 - -
  TT / CC / AA 3 2.4 3 2.0 1 3.2 6 2.9 0 0.0 0 0.0 - -
  TT / CT / AA 3 2.4 5 3.4 1 3.2 6 2.9 3 3.8 0 0.0 - -
  TT / CT / GA 2 1.6 2 1.4 0 0.0 3 1.5 1 1.3 0 0.0 - -
  TT / TT / AA 1 0.8 0 0.0 0 0.0 1 0.5 0 0.0 1 4.8 - -
  TT / TT / GA 4 3.2 2 1.4 0 0.0 4 2.0 2 2.6 0 0.0 - -
  TT / TT / GG 3 2.4 1 0.7 0 0.0 3 1.5 1 1.3 0 0.0 - -
High-grade myopia Any myopia  
   
Affected Unaffected Unknown Affected Unaffected Unknown
Population
     group
SNP SNP genotype/
allele n % n % n % n % n % n % n %Molecular Vision 2011; 17:2428-2439 <http://www.molvis.org/molvis/v17/a264> © 2011 Molecular Vision
TABLE 3. FAMILY-BASED ASSOCIATION TEST ANALYSES (FBAT) AND PEDIGREE DISEQUILIBRIUM TEST (PDT) ANALYSES OF THE IGF-1 GENE SNPS rs6214,
rs2946834, AND rs10860860.
High-Grade Myopia
 
  FBAT  
    additive                                        dominant                                       recesive                                    PDT
SNP Allele Z p Z p Z p Z p
rs10860860 T −0.781 0.434947 −0.946 0.344327 −0.137 0.890758 −1.068 0.2855
  A 0.781 0.434947 0.137 0.890758 0.946 0.344327 1.068 0.2855
rs2946834 T 0.899 0.368809 0.454 0.649731 1.044 0.296272 0.697 0.4855
  C −0.899 0.368809 −1.044 0.296272 −0.454 0.649731 −0.697 0.4855
rs6214 A −0.052 0.958800 0.234 0.815084 −0.412 0.680280 −0.688 0.4913
  G 0.052 0.958800 0.412 0.680280 −0.234 0.815084 0.688 0.4913
rs10860860/
rs6214
AG −0.347 0.728871 0.340 0.733820 −0.807 0.419469 - -
  TA −0.964 0.335015 −0.812 0.416977 - - - -
  AA 1.345 0.178669 1.606 0.108337 - - - -
  TG −0.003 0.997942 0.308 0.758358 - - - -
rs10860860/
rs2946834
AC −0.016 0.987072 −0.886 0.375848 0.760 0.447395 - -
  TT 0.667 0.504478 0.695 0.487210 - - - -
  TC −2.331 0.019747 −2.723 0.006470 - - - -
  AT 1.898 0.057721 1.898 0.057721 - - - -
rs2946834/
rs6214
CG −1.472 0.141034 −1.464 0.143106 −0.662 0.508095 - -
  CA −0.364 0.715703 −0.906 0.364933 - - - -
  TG 1.172 0.241160 1.358 0.174527 - - - -
  TA 1.433 0.151778 1.433 0.151778 - - - -
rs10860860/
rs2946834/
rs6214
ACG −1.467 0.142408 −1.425 0.154041 −0.698 0.484867 - -
  TCA −2.145 0.031928 −2.528 0.011472 - - - -
  ACA 1.743 0.081412 1.781 0.074903 - - - -
  ATG 1.449 0.147280 1.449 0.147280 - - - -
  TTA 0.830 0.406764 0.830 0.406764 - - - -
  TTG 0.438 0.661696 0.826 0.409048 - - - -
  ATA - - - - - - - -
  TCG - - - - - - - -
Any Myopia
   
   
SNP Allele Z p Z p Z p Z p
rs10860860 T −1.243 0.213893 −0.636 0.525020 −1.423 0.154872 −1.572 0.1159
  A 1.243 0.213893 1.423 0.154872 0.636 0.525020 1.572 0.1159
rs2946834 T −0.757 0.449004 −0.850 0.395113 −0.199 0.842542 −0.983 0.3258
  C 0.757 0.449004 0.199 0.842542 0.850 0.395113 0.983 0.3258
rs6214 A −0.346 0.729034 0.407 0.684086 −1.063 0.287596 −0.567 0.5708
  G 0.346 0.729034 1.063 0.287596 −0.407 0.684086 0.567 0.5708
rs10860860/
rs6214
AG 0.618 0.536845 1.353 0.176003 −0.393 0.694038 - -
  TA −0.769 0.441736 −0.362 0.717451 - - - -
  AA 0.794 0.427175 1.252 0.210729 - - - -
  TG −1.093 0.274437 −0.829 0.407052 - - - -
rs10860860/
rs2946834
AC 0.801 0.423129 0.813 0.416233 0.471 0.637682 - -
  TT −0.737 0.460854 −0.432 0.665463 - - - -
  TC −0.973 0.330541 −1.256 0.209270 - - - -
  AT 1.211 0.226036 1.405 0.160003 - - - -
rs2946834/
rs6214
CG −0.672 0.501768 −0.81 0.417700 −0.201 0.840646 - -
  TG 0.276 0.782902 −0.421 0.673876 - - - -
  CA 0.526 0.59913 0.88 0.379065 - - - -
  TA 0.1 0.920244 0.325 0.745094 - - - -
rs10860860/
rs2946834/
rs6214
ACG −0.270 0.786807 −0.552 0.580836 0.162 0.871179 - -
  TCA −0.539 0.590146 −0.902 0.367010 - - - -
  ACA 1.245 0.213008 1.122 0.261914 - - - -
  ATG 1.027 0.304204 1.251 0.211033 - - - -
  TTA −0.385 0.700077 −0.179 0.857572 - - - -
  TTG −0.474 0.635663 −0.111 0.911560 - - - -
  ATA - - - - - - - -
  TCG - - - - - - - -
2434
  FBAT  
  additive                                        dominant                                       recesive                                    PDTcases, subjects classified as having an unknown myopia status
in our study would be classified as having HM data published
by Metlapally et al. [49]. Moreover, in our study, individuals
with  any  myopia  who  did  fulfill  the  criteria  for  HM  or
unknown  status  were  treated  as  unaffected  individuals.
Metlapally et al. [49] found a significant association between
HM and the SNPs rs6214 and rs10860860, as well as any
myopia (including low and medium myopia) and the SNPs
rs6214,rs10860860, and rs2946834, out of 13 tested SNPs in
IGF-1. Therefore, we performed an additional analysis using
the any myopia phenotype criteria described by Metlapally et
al.  [49].  Again,  the  FBAT  and  PDT  analyses  showed  no
positive  association  between  the  IGF-1  SNPs  rs6214,
rs10860860, and rs2946834 and any myopia phenotype.
Metlapally et al. [49] defined the statistical significance
as p≤0.0038, which is in the range where false-positive results
are  common  [84].  Another  study  has  proposed  that
p≤5×10−5 or even p≤2×10−7 provides a ratio of a truly positive,
reproducible association for candidate genes [87]. Although
association  studies  have  identified  many  putative  disease
genes, these have often been difficult to confirm. According
to Manly [87], irreproducibility might be a consequence of
weak statistical power of the original work. Manley’s Better
Association for Disease and Gene (BADGE) classification
suggests  that  first-class  (p≤2×10−7)  and  second-class
(5×10−6)  associations  provide  some  assurance  of
reproducibility.  However,  the  reliability  of  second-class
associations depends on assumptions. As these criteria are not
fulfilled in the Metlapally et al. [49] study, theoretically, their
results will be difficult to replicate in subsequent studies. It is
possible that the use of more stringent statistic criteria for
positive  genetic  association  [88,89]  might  yield  different
study findings.
In conclusion, our study revealed no evidence to support
the previously reported genetic association of the IGF-1 gene
polymorphisms rs6214, rs10860860, and rs2946834 with HM
and any myopia phenotypes in Polish families.
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Appendix 1. Clinical information data for any myopia
state. To access the data, click or select the words “Appendix
1.” This will initiate the download of a compressed (pdf)
archive that contains the file.
Appendix 2. The PCR and PCR-RFLP conditions for
SNPs  rs6214,  rs10860860,  and  rs2946834  analyses.  *The
SNP  rs2946834  genotypes  were  determined  by  direct
sequencing. Due to a lack of a restriction site for rs2946834,
the PCR-RFLP assay was not performed. To access the data,
click or select the words “Appendix 2.” This will initiate the
download of a compressed (pdf) archive that contains the file.
Appendix 3. Detailed clinical findings in family HM-14.
*SPH- spherical refractive error, †CYL - cylindrical refractive
error. To access the data, click or select the words “Appendix
3.” This will initiate the download of a compressed (pdf)
archive that contains the file.
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